e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
Metabolic and cardiovascular consequences of OSA II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Association of cardiovascular diseases, metabolic syndrome and obstructive sleep apnea: Data from 1,000 Japanease PSG cases
A. Matsuo, M. Kosaka, N. Kobayashi, T. Horiuchi, T. Agatsuma, A. Ushiki, S. Kanda, K. Keishi (Nagano, Matsumoto, Japan)
Source:
Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Session:
Metabolic and cardiovascular consequences of OSA II
Session type:
Thematic Poster Session
Number:
3867
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Matsuo, M. Kosaka, N. Kobayashi, T. Horiuchi, T. Agatsuma, A. Ushiki, S. Kanda, K. Keishi (Nagano, Matsumoto, Japan). Association of cardiovascular diseases, metabolic syndrome and obstructive sleep apnea: Data from 1,000 Japanease PSG cases. Eur Respir J 2012; 40: Suppl. 56, 3867
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
Clinical case discussion: ERS guidelines on high flow nasal cannula in acute respiratory failure: from the clinical cases to the scientific evidence
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
Related content which might interest you:
Genetic determinants of cardiovascular disease in patients with obstructive sleep apnea (OSA)
Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing
Year: 2015
Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008
Obstructive sleep apnea and metabolic syndrome in 1,600 adult Japanease PSG cases.
Source: International Congress 2018 – Sleep and breathing control: phenotypes
Year: 2018
Association between obstructive sleep apnoea (OSA) severity and metabolic disturbances
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017
Association of obstructive sleep apnea hypopnea syndrome with cardiovascular disease: a candidate gene association study
Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Year: 2020
Transition from obstructive sleep apnea (OSA) to obesity hypoventilation syndrome (OHS)
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies
Year: 2015
Screening for obstructive sleep apnoea (OSA) in patients attending a hypertension clinic with features of the metabolic syndrome
Source: Annual Congress 2012 - Snoring and scoring: subjective and objective measures of sleep-disordered breathing
Year: 2012
Association between metabolic disturbances and inflammatory markers in obstructive sleep apnea (OSAS) patients
Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Year: 2008
Correlations between cardiovascular diseases and diabetes in obstructive sleep apnoea (OSA)
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012
Prevalence of obstructive sleep apnea syndrome in patients with risk factors for cardiovascular diseases in a large population in Zaragoza (Spain)
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014
Prevalence of obstructive sleep apnea syndrome (OSAS) in men varies markedly according to definition criteria
Source: International Congress 2016 – Comorbid sleep apnoea in specific clinical entities and differential diagnosis of sleep disorders
Year: 2016
Association between smoking and concomitant diseases in obstructive sleep apnoea (OSA)
Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II
Year: 2015
Association between daytime hypersomnolence and the metabolic syndrome in men with obstructive sleep apnea
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009
Asthma, obesity, metabolic dysfunction and obstructive sleep apnoea
Source: International Congress 2019 – State of the art session: Sleep and breathing disorders
Year: 2019
Prevalence of metabolic syndrome with obstructive sleep apnea in a Korean population
Source: Annual Congress 2013 –Sleep disordered breathing in special situations III
Year: 2013
Obstructive sleep apnea syndrome and cardiovascular diseases risk in patients with COPD
Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA
Year: 2012
The prevalance of cardiovascular disorders in patients with obstructive sleep apnoea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 293s
Year: 2002
Prevalence of metabolic syndrome in patients with hypertension and obstructive sleep apnea
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
The investigation of relationship between red cell distribution width and cardiovascular diseases in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2013 –Sleep disordered breathing in special situations I
Year: 2013
Cardiovascular risk, insulin resistance and metabolic syndrome in patients with obstructive sleep apnea
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept